China Traditional Chinese Medicine Holdings Co. Limited provided preliminary unaudited consolidated earnings guidance for the year ended 31 December 2023. For the year, the group expects net profit would increase by 85%-95% as compared to that for the same period in 2022.

The Board considers that benefited from the stable domestic macro economy with good momentum for growth, the Group has promoted business growth with multiple measures, and continuously carried out work to improve quality and efficiency. Non-recurring gains increased while non-recurring losses decreased for the Period, so that net profit for the Period showed considerable growth.